Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma

Autor: Kang, Y.-K. *, Yau, T., Park, J.-W., Lim, H.Y., Lee, T.-Y., Obi, S., Chan, S.L., Qin, S.K., Kim, R.D., Casey, M., Chen, C., Bhattacharyya, H., Williams, J.A., Valota, O., Chakrabarti, D., Kudo, M.
Zdroj: In Annals of Oncology December 2015 26(12):2457-2463
Databáze: ScienceDirect